A
Annelyse Duvoix
Researcher at University of Cambridge
Publications - 36
Citations - 3558
Annelyse Duvoix is an academic researcher from University of Cambridge. The author has contributed to research in topics: COPD & Glutathione S-transferase. The author has an hindex of 21, co-authored 36 publications receiving 3221 citations. Previous affiliations of Annelyse Duvoix include University of Oxford & University of Bedfordshire.
Papers
More filters
Journal ArticleDOI
Chemopreventive and therapeutic effects of curcumin.
Annelyse Duvoix,Romain Blasius,Sylvie Delhalle,Michael Schnekenburger,Franck Morceau,Estelle Henry,Mario Dicato,Marc Diederich +7 more
TL;DR: Curcumin is described as an anti-tumoral, anti-oxidant and anti-inflammatory agent capable of inducing apoptosis in numerous cellular systems capable of suppression, retardation or inversion of carcinogenesis.
Journal ArticleDOI
Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers
Mona Bafadhel,S McKenna,Sarah Terry,Vijay Mistry,C Reid,Pranabashis Haldar,M McCormick,Koirobi Haldar,Tatiana Kebadze,Annelyse Duvoix,Kerstin Lindblad,Hemu Patel,Paul Rugman,Paul Dodson,Martin Jenkins,Michael A. Saunders,Paul Newbold,Ruth H. Green,Per Venge,David A. Lomas,Michael R. Barer,Sebastian L. Johnston,Ian D. Pavord,Christopher E. Brightling +23 more
TL;DR: In this paper, the authors investigated biomarker expression in COPD exacerbations to identify biologic clusters and determine biomarkers that recognize clinical exacerbation phenotypes, namely those associated with bacteria, viruses, or eosinophilic airway inflammation.
Journal ArticleDOI
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.
Bartolome R. Celli,Nicholas Locantore,Julie C. Yates,Ruth Tal-Singer,Bruce E. Miller,Per Bakke,Peter M.A. Calverley,Harvey O. Coxson,Courtney Crim,Lisa D. Edwards,David A. Lomas,Annelyse Duvoix,William MacNee,Stephen I. Rennard,Edwin K. Silverman,Jørgen Vestbo,Jørgen Vestbo,Emiel F.M. Wouters,Alvar Agusti +18 more
TL;DR: The addition of a panel of selected biomarkers improves the ability of established clinical variables to predict mortality in chronic obstructive pulmonary disease.
Journal ArticleDOI
The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study
Harvey O. Coxson,Asger Dirksen,Lisa D. Edwards,Julie C. Yates,Alvar Agusti,Per Bakke,Peter M.A. Calverley,Bartolome R. Celli,Courtney Crim,Annelyse Duvoix,Paola V. Nasute Fauerbach,David A. Lomas,William MacNee,Ruth J. Mayer,Bruce E. Miller,Nestor L. Müller,Stephen I. Rennard,Edwin K. Silverman,Ruth Tal-Singer,Emiel F.M. Wouters,Jørgen Vestbo,Jørgen Vestbo +21 more
TL;DR: This study shows that decline in lung density in COPD can be measured, that it is variable, and related to smoking and gender.
Journal ArticleDOI
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
Annelyse Duvoix,Jenny Dickens,Imran Haq,David M. Mannino,Bruce E. Miller,Ruth Tal-Singer,David A. Lomas +6 more
TL;DR: Fibrinogen is likely to be a useful biomarker to stratify individuals with COPD intoThose with a high or low risk of future exacerbations and may identify those with a higher risk of mortality.